Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V, Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., & Hedborg, F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1466 · Cited by 2,294
Conserved Structures and Diversity of Functions of RNA-Binding Proteins
Burd, C. G., & Dreyfuss, G. (1994) · Science · doi:10.1126/science.8036511 · Cited by 1,877
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
“%) in ependymomas, hepatoblastomas, Ewing’s sarcomas (driven by EWSR1 fusions instead of by point mutations 28 ), and pilocytic astrocytomas, and common ( > 90”
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
Self-citationWhole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., & Barr, F. G. (1993) · Nature Genetics · doi:10.1038/ng1193-230 · Cited by 892
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationThe Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Clark, J., Rocques, P. J., Crew, A. J., Gill, S., Shipley, J., Chan, A. M.-L., Gusterson, B. A., & Cooper, C. S. (1994) · Nature Genetics · doi:10.1038/ng0894-502 · Cited by 774
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 722
Self-citationSorensen, P. H. B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., & Barr, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.137 · Cited by 742
Balamuth, N. J., & Womer, R. B. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70286-4 · Cited by 686
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
The emerging complexity of gene fusions in cancer
Mertens, F., Johansson, B., Fioretos, T., & Mitelman, F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3947 · Cited by 682
The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease
King, O. D., Gitler, A. D., & Shorter, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.016 · Cited by 644
The Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 566
“Ewing sarcoma is an aggressive, poorly differentiated tumor, typically arising from bone, and is characterized by highly recurrent translocations involving ETS transcription factors, with EWS–FLI and EWS–ERG translocations being the most common (5, 6).”
BackgroundInfluentialTirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
“2) translocation that fuses the EWSR1 gene on chromosome (chr) 22 with the FLI1 gene on chr 11 (2).”
BackgroundSelf-citationRNA polymerase II and the integration of nuclear events
Hirose, Y., & Manley, J. L. (2000) · Genes & Development · doi:10.1101/gad.14.12.1415 · Cited by 575
“In all cases, chimeric proteins consisting of the amino terminus of the TLS/FUS-related protein fused to the DNA binding domain of a transcriptional activator are created (Delattre et al. 1992; Crozat et al. 1993).”
MethodMay, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Self-citationGenome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
“…result in fusion of a strong transcriptional activator domain to the ETS DBD (e.g. EWS fused to FLI1 or ERG in Ewing’s sarcoma; Delattre et al, 1992; Sorensen et al, 1994) and/or overexpression of an ETS-family member due to introduction of a strong cis-regulatory element…”
InfluentialRabbitts, T. H., Forster, A., Larson, R., & Nathan, P. (1993) · Nature Genetics · doi:10.1038/ng0693-175 · Cited by 554
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., & Emanuel, B. S. (1993) · Nature Genetics · doi:10.1038/ng0293-113 · Cited by 555
Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., & Turc-Carel, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06137.x · Cited by 539
Self-citationEwing's Sarcoma Family of Tumors: Current Management
Bernstein, M., Kovar, H., Paulussen, M., Randall, R. L., Schuck, A., Teot, L. A., & Juergensg, H. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-503 · Cited by 520
Self-citationThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Mesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507
“The most frequent fusion occurs with the FLI1 gene as a consequence of the t(11;22)(q24;q12) translocation (Delattre et al., 1992).”
BackgroundSelf-citationEWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1248 · Cited by 524
Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.
Ladanyi, M., & Gerald, W. L. (1994) · PubMed · Cited by 498
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
“This polypeptide fragment included EWS amino acid residues 244 to 264 (6) fused to residues 241 to 284 of FLI-1 (30).”
BackgroundMethodEWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
Zucman, J., Delattre, O., Desmaze, C., Epstein, A. L., Stenman, G., Speleman, F., Fletchers, C. D. M., Aurias, A., & Thomas, G. (1993) · Nature Genetics · doi:10.1038/ng0893-341 · Cited by 502
Self-citationGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Boulay, G., Sandoval, G. J., Riggi, N., Iyer, S., Buisson, R., Naigles, B., Awad, M. E., Rengarajan, S., Volorio, A., McBride, M. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.036 · Cited by 470
“One of the most well-characterized translocations results in the fusion of the EWSR1 gene and the FLI1 E-Twenty Six (ETS) transcription factor in Ewing sarcoma, the second most common pediatric bone cancer (Delattre et al., 1992).”
BackgroundA new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Pierron, G., Tirode, F., Lucchesi, C., Reynaud, S., Ballet, S., Cohen-Gogo, S., Perrin, V., Coindre, J.-M., & Delattre, O. (2012) · Nature Genetics · doi:10.1038/ng.1107 · Cited by 478
Self-citationCrew, A. J., Clark, J., Fisher, C., Gill, S., Grimer, R., Chand, A., Shipley, J., Gusterson, B. A., & Cooper, C. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07228.x · Cited by 474
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
“In this instance, the FLI1 gene is translocated from its normal 11q24 position to chromosome 22, which generates the formation of chimeric transcripts resulting in the fusion of the amino terminal region of the EWS gene with the carboxyl terminal DNA-binding domain of the FLI1 gene [49].”
BackgroundErkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
“EWS-FLI1 was recognized as a potential therapeutic target over 15 years ago, almost immediately after the protein was identified as a product of the breakpoint region t(11;22”
Kawamura-Saito, M., Yamazaki, Y., Kaneko, K., Kawaguchi, N., Kanda, H., Mukai, H., Gotoh, T., Motoi, T., Fukayama, M., Aburatani, H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl136 · Cited by 459
Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 445
“Ewing sarcoma is characterized by chromosomal translocations that generate fusions between the EWS gene and members of the ETS family of transcription factors, by far the most common being FLI1 (Delattre et al., 1992).”
BackgroundLiquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
Prieur, A., Tirode, F., Cohen, P., & Delattre, O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7275-7283.2004 · Cited by 420
“Ewing tumors, the second most frequent bone tumors in adolescents and young adults, are characterized by the presence of specific gene fusions which most frequently involve the EWS gene on chromosome 22 and the FLI-1 gene on chromosome 11 (8).”
BackgroundSelf-citationGerald, W. L., Ladanyi, M., de Alava, E., Cuatrecasas, M., Kushner, B. H., LaQuaglia, M. P., & Rosai, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3028 · Cited by 417
Antonescu, C. R., Owosho, A. A., Zhang, L., Chen, S., Deniz, K., Huryn, J. M., Kao, Y.-C., Huang, S.-C., Singer, S., Tap, W., et al. (2017) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000846 · Cited by 405
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies
Centore, R. C., Sandoval, G. J., Soares, L. M. M., Kadoch, C., & Chan, H. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.07.011 · Cited by 387
Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., & Naeve, C. W. (1993) · PubMed · Cited by 383
Wilms' tumour: connecting tumorigenesis and organ development in the kidney
Rivera, M. N., & Haber, D. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1696 · Cited by 375
“The NTD of EWSR1 mediates potent transactivating activit”
BackgroundRiggi, N., Suvà, M. L., & Stamenkovic, I. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2028910 · Cited by 344
The ETS family of oncogenic transcription factors in solid tumours
Sizemore, G. M., Pitarresi, J. R., Balakrishnan, S., & Ostrowski, M. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.20 · Cited by 367
Hart, A., Melet, F., Grossfeld, P., Chien, K., Jones, C., Tunnacliffe, A., Favier, R., & Bernstein, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00017-0 · Cited by 369
“…activation of Fli-1 by either chro-Samuel Lunenfeld Research Institute mosomal translocation or proviral insertion leads to Ew-Mount Sinai Hospital ings sarcoma in humans (Delattre et al., 1992) and eryth-600 University Avenue roleukemia in mice, respectively (Ben David et al., 1991).”
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Kaloulis, K., Garcia-Echeverria, C., Hoffmann, F., Trumpp, A., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1696 · Cited by 359
“However, by far the most common fusion occurs with the FLI-1 gene resulting from the translocation t(11;22)(q24:q12) (5).”
BackgroundExpression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
“The identification of EWS/FLI over a decade ago suggested that more specific and less toxic therapies for Ewing’s sarcoma would be feasible (Delattre et al., 1992).”
BackgroundBertolotti, A., Lutz, Y., Heard, D. J., Chambon, P., & Tora, L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00882.x · Cited by 365
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225525 · Cited by 353
“EWSR1-FLI1, an oncogenic fusion gene detected in 85% of patients with Ewing sarcoma [193,194], is a transcription factor that controls the expression of over 500 genes which suppress cellular differentiation and facilitate cellular proliferation [195].”
BackgroundMolecular Biology of the Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Family
de Alava, E., & Gerald, W. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.204 · Cited by 360
Andersson, M. K., Ståhlberg, A., Arvidsson, Y., Olofsson, A., Semb, H., Stenman, G., Nilsson, O., & Åman, P. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-37 · Cited by 345
“The FET family consists of mammalian FUS (TLS) [4], EWS [5], TAF15 (TAFII68, TAF2N, RBP56) [3] and the closely related Drosophila cabeza/SARFH [6].”
TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1741 · Cited by 350
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
“These e ects are associated in vitro with a shift in cell cycle pro®le towards G0/G1 and are apparent in vivo even if antisense oligonucleotides are given exogenously after Table 1 Listing of cancer-associated gene fusions involving TET family members Karyotype Fusion Malignancy Reference t(11;22)(q24;q12) EWS/FLI1 EF…”
BackgroundInfluentialBailly, R.-A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., & Ghysdael, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3230-3241.1994 · Cited by 297
Self-citationHahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348
“We generated MFG-asTGF-β1 by PCR using human TGFB1 cDNA containing the 5′ UTR of TGFB1 as a templat”
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Robinson, D. R., Kalyana-Sundaram, S., Wu, Y.-M., Shankar, S., Cao, X., Ateeq, B., Asangani, I. A., Iyer, M., Maher, C. A., Grasso, C. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2580 · Cited by 340
“Recurrent gene fusions and translocations have long been associated with hematologic malignancies and rare soft-tissue tumors as being 'driving' genetic lesion”
BackgroundRiggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J.-M., Stehle, J.-C., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 332
“More than 85% of Ewing’s sarcoma family tumors (ESFT) are associated with the chromosomal translocation t(11;22)(q24;q12) that generates the EWS-FLI-1 fusion gene (1).”
BackgroundFusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Schram, A. M., Chang, M. T., Jonsson, P., & Drilon, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.127 · Cited by 323
Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia
Golub, T. R., Goga, A., Barker, G. F., Afar, D. E. H., McLaughlin, J., Bohlander, S. K., Rowley, J. D., Witte, O. N., & Gilliland, D. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4107 · Cited by 324
“Other Ets proteins have been shown to be rearranged in human malignancies, including ERG in myeloid leukemia (46) and FLI-1, ERG, and ETV1 in Ewing’s sarcoma (10, 20, 48).”
BackgroundIdentification of Cancer Stem Cells in Ewing's Sarcoma
Suvà, M.-L., Riggi, N., Stehle, J.-C., Baumer, K., Tercier, S., Joseph, J.-M., Suvà, D., Clément, V., Provero, P., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2242 · Cited by 302
“ESFTs typically harbor a specific chromosomal translocation that results in the fusion of the 5¶ portion of the EWS gene to the 3¶ portion of one of at least five genes that encode ETS family transcription factors, including FLI1, ERG, ETV1, ETV4 , and FEV (1, 2).”
BackgroundGerald, W. L., Rosai, J., & Ladanyi, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1028 · Cited by 301
Riggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 282
Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297
“Ewing’s sarcoma is a highly malignant solid tumor of children and young adults that usually harbors a recurrent chromosomal translocation, t(11;22)(q24;q12), that encodes the EWS/FLI fusion oncoprotein (10).”
BackgroundEwing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081685 · Cited by 271
“In 85–95% of all EwS patients, this rearrangement fuses the Ewing sarcoma breakpoint region 1 gene (EWSR1) on chromosome 22 to the friend of leukemia virus integration site 1 gene (FLI1) on chromosome 11 t(11;22)(q24;q12) [13].”
BackgroundSelf-citationPathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases
Uversky, V. N., Davé, V., Iakoucheva, L. M., Malaney, P., Metallo, S. J., Pathak, R. R., & Joerger, A. C. (2014) · Chemical Reviews · doi:10.1021/cr400713r · Cited by 288
Lee, S. B., & Haber, D. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5131 · Cited by 288
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
“A recent study has investigated the molecular basis of the translocation resulting in synthesis of the EWS-Fli1 fusion gene (3).”
BackgroundInfluentialSkubitz, K. M., & D'Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 277
The TET Family of Proteins: Functions and Roles in Disease
Tan, A. Y., & Manley, J. L. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp025 · Cited by 270
“This region is reminiscent of the heptapeptide repeats that constitute the carboxy-terminal domain (CTD) of the RNA polymerase (RNAP) II largest subunit, and the high Gln and Pro content is similar to activation domains of various transcription factors (Delattre et al., 1992).”
BackgroundRiggi, N., Suvà, M.-L., De Vito, C., Provero, P., Stehle, J.-C., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., et al. (2010) · Genes & Development · doi:10.1101/gad.1899710 · Cited by 279
“…translocation fuses the 59 end of the EWS gene to the 39 end of the FLI-1 gene, giving rise to the EWS-FLI-1 fusion protein where sequences containing the potent EWS transactivation domain are joined to sequences containing the DNAbinding domain (DBD) of FLI-1 (Delattre et al. 1992).”
BackgroundFusion of ETV6 to Neurotrophin-3 Receptor TRKC in Acute Myeloid Leukemia With t(12;15)(p13;q25)
Eguchi, M., Eguchi-Ishimae, M., Tojo, A., Morishita, K., Suzuki, K., Sato, Y., Kudoh, S., Tanaka, K., Setoyama, M., Nagamura, F., et al. (1999) · Blood · doi:10.1182/blood.v93.4.1355 · Cited by 281
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
“The second most common subtype (originally called a “type II” fusion) fuses exon 7 of EWSR1 to exon 5 of FLI1 (19) (Fig.”
BackgroundInfluentialCarroll, M., Tomasson, M. H., Barker, G. F., Golub, T. R., & Gilliland, D. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14845 · Cited by 268
Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., & Tora, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1489 · Cited by 261
“Since the N-terminal domains of EWS and TLS/FUS play a specific role in tumorigenic processes (7, 8), it is important to characterize the interactions in which the N-terminal region of the TET proteins are involved.”
BackgroundSelf-citationFUS/ERG gene fusions in Ewing's tumors.
Shing, D. C., McMullan, D. J., Roberts, P., Smith, K. K., Chin, S., Nicholson, J. C., Tillman, R. M., Ramani, P., Cullinane, C., & Coleman, N. (2003) · PubMed · Cited by 265
Lessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
“protein containing the amino terminus of the EWS protein joined To address the functional consequences of EWS/FLI in prito the carboxyl terminus of the FLI1 protein, an ETS transcription mary cells, we report here the establishment of telomerasefactor (Dellatre et al., 1992).”
BackgroundZinszner, H., Albalat, R., & Ron, D. (1994) · Genes & Development · doi:10.1101/gad.8.21.2513 · Cited by 264
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Sheffield, N. C., Pierron, G., Klughammer, J., Datlinger, P., Schönegger, A., Schuster, M., Hadler, J., Surdez, D., Guillemot, D., Lapouble, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4273 · Cited by 249
Self-citationVucetic, S., Xie, H., Iakoucheva, L. M., Oldfield, C. J., Dunker, A. K., Obradovic, Z., & Uversky, V. N. (2007) · Journal of Proteome Research · doi:10.1021/pr060393m · Cited by 256
Huang, H.-Y., Illei, P. B., Zhao, Z., Mazumdar, M., Huvos, A. G., Healey, J. H., Wexler, L. H., Gorlick, R., Meyers, P., & Ladanyi, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.081 · Cited by 248
Assemblages: Functional units formed by cellular phase separation
Toretsky, J. A., & Wright, P. E. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404124 · Cited by 252
“First, chromosomal translocation of EWS in Ewing sarcoma (ES) became recognized as a fusion partner in many cancer phenotypes bearing little phenotypic relationship to ES (Delattre et al., 1992; Kovar, 2011).”
Paulussen, M., Ahrens, S., Craft, A. W., Dunst, J., Fröhlich, B., Jabar, S., Rübe, C., Winkelmann, W., Wissing, S., Zoubek, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3044 · Cited by 249
Male sterility and enhanced radiation sensitivity in TLS-/- mice
Kuroda, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.453 · Cited by 244
“…deleted from the aforementioned fusion oncoproteins, contain R-G-G repeats flanking a highly conserved RNA binding domain of the RRM type (Delattre et al., 1992; Crozat et al., 1993; Rabbitts et al., 1993); TLS binds RNA in vitro and in vivo (Crozat et al., 1993; Prasad et al., 1994;…”
BackgroundThe Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts
Toretsky, J. A., Kalebic, T., Blakesley, V., LeRoith, D., & Helman, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30822 · Cited by 250
Ludwig, J. A. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328303ba1d · Cited by 240
Specht, K., Sung, Y., Zhang, L., Richter, G. H. S., Fletcher, C. D., & Antonescu, C. R. (2014) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22172 · Cited by 242
“…the pathognomonic translocations involving the EWSR1 gene on chromosome 22 fused to a member of the ETS transcription factor family, namely, FLI1 (Delattre et al., 1992), ERG (Zucman et al., 1993; Sorensen et al., 1994), ETV1 (Jeon et al., 1995), ETV4 (Urano et al., 1996), or FEV (Peter et al.,…”
BackgroundMarcucci, G., Baldus, C. D., Ruppert, A. S., Radmacher, M. D., Mrózek, K., Whitman, S. P., Kolitz, J. E., Edwards, C. G., Vardiman, J. W., Powell, B. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6137 · Cited by 236
Kaneko, Y., Yoshida, K., Handa, M., Toyoda, Y., Nishihira, H., Tanaka, Y., Sasaki, Y., Ishida, S., Higashino, F., & Fujinaga, K. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<115::aid-gcc6>3.0.co;2-6 · Cited by 239
Diagnosis and Treatment of Ewing's Sarcoma
Iwamoto, Y. (2007) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl142 · Cited by 229
“Identification of a common translocation t(11;22)(q24;q12) (7,8) that results in the formation of the EWS–ETS fusion gene (9) in cases of Ewing’s sarcoma, PNET and Askin’s tumor strongly supported the hypothesis that these tumors are related.”
BackgroundFranzetti, G.-A., Laud-Duval, K., van der Ent, W., Brisac, A., Irondelle, M., Aubert, S., Dirksen, U., Bouvier, C., de Pinieux, G., Snaar-Jagalska, E., et al. (2017) · Oncogene · doi:10.1038/onc.2016.498 · Cited by 219
Self-citationChromosomal Abnormalities in Cancer
Fröhling, S., & Döhner, H. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0803109 · Cited by 229
Rossi, S., Orvieto, E., Furlanetto, A., Laurino, L., Ninfo, V., & Tos, A. P. D. (2004) · Modern Pathology · doi:10.1038/modpathol.3800065 · Cited by 226
“The resultant EWSsFLI-1 chimeric protein includes the N-terminal transactivation domain of EWS and the C-terminal DNA-binding domain of FLI-1”
Background
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.